Isabelle Ruel

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Journal: Atherosclerosis

Published: March 20, 2026

Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.

Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.

Journal: Atherosclerosis

Published: December 15, 2025

Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration.

Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration.

Journal: Atherosclerosis

Published: October 08, 2025

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.

Journal: JACC. Advances

Published: August 14, 2025

Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.

Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.

Journal: European journal of preventive cardiology

Published: August 08, 2025

Low-Dose Docetaxel Is Effective in Reducing Atherogenic Lipids and Atherosclerosis.

Low-Dose Docetaxel Is Effective in Reducing Atherogenic Lipids and Atherosclerosis.

Journal: International journal of molecular sciences

Published: January 10, 2025

Polygenic risk score for coronary artery disease predicts atherosclerotic cardiovascular disease in familial hypercholesterolemia.

Polygenic risk score for coronary artery disease predicts atherosclerotic cardiovascular disease in familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: December 12, 2024

Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.

Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 23, 2024

Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia.

Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: May 22, 2024

Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis.

Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis.

Journal: European heart journal

Published: February 03, 2024

Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia.

Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: November 17, 2023

Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study.

Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study.

Journal: CMAJ open

Published: August 22, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026